CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non–Small Cell Lung Cancer
Authors:
Open Access
- 15 July 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 10 (14) , 4734-4741
Abstract
Purpose and Experimental Design: The molecular mechanisms by which the p14ARF gene is altered in non–small cell lung cancer (NSCLC) are complex and unclear. Using genetic and epigenetic analyses, we examined various molecular alterations including the loss of protein and mRNA expression, and 5′CpG hypermethylation, allelic imbalance, and mutation of the p14ARF gene in a series of 102 NSCLC samples, in parallel with clinicopathological and prognostic analyses. To clarify the biological significance of p14ARF alterations, its relationship with p16INK4a and p53 alterations was also examined. Results: We found that 34% of NSCLC patients had aberrant P14ARF protein expression, which was more frequent in adenocarcinomas (AD; 44%) than in squamous cell carcinomas (22%; P = 0.024). A high concordance was observed between alterations in protein and mRNA expression and 5′CpG hypermethylation (P ≤ 0.001). The p14ARF hypermethylation inversely correlated with P53 overexpression (P = 0.001). This mutually exclusive relationship for alteration between p14ARF and p53 was also supported by a worse prognosis of AD patients with positive P14ARF expression (P = 0.01) and of AD patients with P53 overexpression (P = 0.006). Our data also indicated that hemizygous/homozygous deletion and mutation in the p14ARF gene occurred at 26%, 9%, and 0%, respectively, of microdissected NSCLCs. Conclusions: Our data suggest that p14ARF 5′CpG hypermethylation is the predominant mechanism involved in the aberrant expression of the p14ARF gene. In addition, p14ARF 5′CpG hypermethylation occurs inversely to P53 overexpression.Keywords
This publication has 23 references indexed in Scilit:
- TheTP53 gene, tobacco exposure, and lung cancerHuman Mutation, 2003
- Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinomaCancer Genetics and Cytogenetics, 2003
- Alterations of the p16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputumInternational Journal of Cancer, 2002
- Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancerOncogene, 1999
- Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung CarcinomasThe American Journal of Pathology, 1998
- Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpressionOncogene, 1998
- The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2The EMBO Journal, 1998
- Mechanisms of p16INK4A inactivation in non small-cell lung cancersOncogene, 1998
- Cancer Cell CyclesScience, 1996
- Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.Proceedings of the National Academy of Sciences, 1996